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Identification of APC2, a homologue of the adenomatous
polyposis coli tumour suppressor
J.H. van Es*, C. Kirkpatrick†, M. van de Wetering*, M. Molenaar‡, A. Miles*,
J. Kuipers*, O. Destrée‡, M. Peifer† and H. Clevers*
The adenomatous polyposis coli (APC) tumour-
suppressor protein controls the Wnt signalling pathway
by forming a complex with glycogen synthase kinase 3b
(GSK-3b), axin/conductin and b-catenin. Complex
formation induces the rapid degradation of b-catenin. In
colon carcinoma cells, loss of APC leads to the
accumulation of b-catenin in the nucleus, where it binds
to and activates the Tcf-4 transcription factor (reviewed
in [1,2]). Here, we report the identification and genomic
structure of APC homologues. Mammalian APC2, which
closely resembles APC in overall domain structure, was
functionally analyzed and shown to contain two SAMP
domains, both of which are required for binding to
conductin. Like APC, APC2 regulates the formation of
active b-catenin–Tcf complexes, as demonstrated using
transient transcriptional activation assays in APC–/–
colon carcinoma cells. Human APC2 maps to
chromosome 19p13.3. APC and APC2 may therefore
have comparable functions in development and cancer.
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Results and discussion
The tumour-suppressor gene APC is conserved from man
to fly [2,3]. A search of mammalian expressed sequence
tag (EST) databases for sequences showing homology to
the human APC sequence revealed a human foetal brain
EST clone (H50183), encoding a protein fragment with
significant similarity to Armadillo repeats 2–6 of all known
APC proteins. We tentatively termed the corresponding
gene APC2. We then searched a Drosophila EST database,
which revealed the existence of two clones (LD18122 and
LD24920) related to the known Drosophila APC gene
(dAPC). The sequencing of these nearly full-length cDNA
clones confirmed the existence of a second APC gene in
the fruit fly (see Supplementary material published with
this article on the internet). 
The tissue-specific expression of APC2 was compared to
that of APC by probing dot blots of normalized poly(A)
mRNA (RNA Master BlotTM 7770–1, Clonetech). Like
APC, the highest levels of expression of APC2 were found
throughout the central nervous system (see Supplemen-
tary material). We subsequently screened human foetal
kidney and brain cDNA libraries, a human Pac
(P1-derived artificial chromosome library) and a mouse
genomic P1 library. Compilation of sequences revealed an
open reading frame of 2274 amino acids for mouse APC2
and 2302 amino acids for human APC2. The mouse APC2
gene spans 14 kb and consists of 14 exons (see Supple-
mentary material). In Figure 1a, the domain structures of
human APC and mouse APC2 are compared. The highest
similarity occurred in the amino-terminal 728 amino acids.
Carboxy-terminal to the Armadillo repeat region, the
homology dropped steeply. Despite this, protein sequence
motifs that are believed to allow APC to interact with 
β-catenin, the so-called ‘20 amino acid repeats’ [2], could
readily be identified. Somewhat surprisingly, the ‘15
amino acid repeats’, which in APC have been proven to
bind β-catenin [2], appeared to be absent in APC2. In
APC, three SAMP domains are interspersed between the
20 amino acid repeats and mediate binding to axin/con-
ductin [4–7], whereas only two SAMP domains were found
in APC2. The region of APC containing the 20 amino acid
repeats and SAMP domains has been shown to harbour the
functional regions required for the control of β-catenin in
colorectal cancer cells and in Xenopus axis induction [8,9].
Because APC2 is an obvious candidate disease gene, we
determined the chromosomal localization of the human
APC2 gene by fluorescence in situ hybridization (FISH)
analysis of metaphase chromosomes from human leuko-
cytes. The gene could be unambiguously assigned to chro-
mosome 19p13.3 (Figure 2). The murine P1 genomic clone
contained, next to the complete mouse APC2 gene, the
proprotein convertase 4 gene, which has been mapped to
chromosome 10 in mouse and chromosome 19 in man [10].
APC controls the Wnt signalling pathway through its
ability to form a complex with GSK-3β, axin/conductin
and β-catenin. In the currently held scenario, β-catenin is
believed to be phosphorylated by GSK-3β when it partici-
pates in this complex [1,5–7]. This modification of 
β-catenin induces its ubiquitination and subsequent
destruction by the proteasome [11]. Wnt signalling
decreases the activity of GSK-3β. The consequent alter-
ation of the phosphorylation state of β-catenin rescues it
from destruction and allows it to travel to the nucleus,
where it associates with T-cell factor (Tcf) transcription
factors [12–17]. This association results in the transcrip-
tional activation of Tcf target genes. In colon cancer and
melanoma, mutations in APC or β-catenin induce the con-
stitutive formation of nuclear β-catenin–Tcf complexes,
resulting in constitutive transcription of target genes
[18–20], such as c-myc [21]. The activity of Tcf-4 is essen-
tial for the maintenance of stem cells in the intestine [22]. 
In the yeast two-hybrid assay, the APC2 SAMP domains
interacted with conductin. But it should be noted that
both SAMP domains were necessary for the interaction
(Figure 3). This contrasted with the observation that a
single APC SAMP domain suffices for the interaction with
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Figure 2
Human APC2 maps to chromosome 19p13.3. FISH was performed on
metaphase chromosomes derived from phytohaemagglutinin-
stimulated human blood cells using standard procedures. The
metaphase ‘spreads’ of human leukocytes were hybridized with a 6 kb
APC2-specific probe. The APC2 signal appears in red. The inset
shows an overlay of the APC2 signal with a green chromosomal
staining of chromosome 19.
Figure 1
A novel mammalian APC homologue.
(a) Comparison of human APC with mouse
APC2. Domains conserved between the APC
relatives are indicated by boxes. DLG, Discs
large protein. (b) The homologies between
the 20 amino acid repeats and SAMP
domains of human APC, human APC2 and
mouse APC2 are shown. Genbank accession
numbers for the APC2 genes are as follows:
mouse APC2, AJ130783–AJ130796; human
APC2 cDNA (corresponding to amino acids
1–705), AJ012652; and exon 14, AJ131187.
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20 amino acid repeats
hAPC rpt1 EDTPICFSRCSSLSSLSSAED
mAPC2 rpt1 QDGPMSLSRCSSLSSLSSTGH
hAPC2 rpt1 QEGPLSLSRCSSLSSLSSAGR
hAPC rpt2 QETPLMFSRCTSVSSLDSFES
mAPC2 rpt2 QETPLVLSRCSSVSSLGSFES
hAPC2 rpt2 QETPLVLSRCSSVSSLGSFES
hAPC rpt3 ESTPDGFSCSSSLSALSLEEP
mAPC2 rpt3 EKPDENFSCASSLSALALHEL
hAPC2 rpt3 EKPDENFSCASSLSALALHEH
hAPC rpt4 EGTPINFSTATSLSDLTIEEP
mAPC2 rpt4 EGTPVNFSSAASLSDETLQGP
hAPC2 rpt4 EGTPVNFSSAASLSDETLQGP
hAPC rpt5 EGTPYCFSRNDSLSSLDFDDD
hAPC rpt6 ENTPVCFSHNSSLSSLSDIDQ
mAPC2 rpt5 DETPPCYSLTSSASSLSEPEA
hAPC2 rpt5 DETPPCYSLTSSASSLSEPEH
hAPC rpt7 EDTPVCFSRNSSLSSLSIDSE
SAMP repeats
APC SDDDDIEILEECIISAMPTKSSRKAKKLA
APC NKAEEGDILAECINSAMPKGKSHKPFRVK
APC SIDSEDDLLQECISSAMPKKK 
 
RPSRLK
mAPC2 ATDKELEALRECLGAAMPARLRKVASALV
hAPC2 AADQELELLRECLGAAVPARLRKVASALV
mAPC2 SPRAEEELLQRCISLAMPRRRYQVPGSRR
hAPC2 SPRAAEELLQRCISSALPRRRPPVSGLRR
(a)
(b)
conductin (Figure 3) [4]. This suggests differences either
in the affinity of the interactions between APC2 or APC
and conduction, or in the local protein structure of the
SAMP domains.
In APC2, the presence of conserved interaction domains for
β-catenin and for axin/conductin predicted its involvement
in the control of β-catenin-mediated Tcf target gene tran-
scription. To test this idea directly, we applied a well-estab-
lished functional assay: the transient Tcf transcription assay
[12,13]. Transfections of reporter plasmids that contain
either three optimal (TOP) or three mutant (FOP) Tcf-
binding sites have demonstrated that Tcf factors activate
transcription only when bound to β-catenin [12,13]. In
colon carcinoma cells lacking APC or expressing a mutant
form of β-catenin, the deregulation of β-catenin results in
the inappropriate transcription of Tcf reporter plasmids
[18,19]. The transfection of wild-type APC restores this
control in APC–/– cells, but not in cells expressing mutant β-
catenin [18,19]. Using this assay, we tested whether APC2
could complement APC function in colon carcinoma cells.
Indeed, transfection of either APC2 or APC in the APC–/–
mutant SW480 (Figure 4a) or DLD-1 (data not shown) cells
inhibited the inappropriate activation of the Tcf reporter
plasmid. As expected, no effects of APC2 or APC were seen
in the HCT116 cell line, which expresses mutant β-catenin
(Figure 4b) or in several control cell lines (data not shown).
Importantly, APC2 and APC did not downregulate the
activity of the mutant reporter plasmid or the co-transfected
Renilla luciferase  control plasmid (pRL-TK; Figure 4). In
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Figure 3
Conductin binds to the SAMP domains of
APC2 in the yeast two-hybrid assay. The
yeast strain HF7c was co-transformed with
one plasmid encoding the indicated APC2
fragment fused to the VP16 activation domain
(AD) and another encoding the RGS domain
of conductin fused to the GAL4 DNA-binding
domain (PGBT9-RGS) or the empty vector
(PGBT9). The presence of the two plasmids
allows growth on selective LT plates, and a
positive interaction between the two fusion
proteins allows growth on selective LTH
plates which contain 20 mM 3-amino-1,2,4-
triazole (3-AT). As a positive control, APC
fragments 1 and 2 were used with PGBT9-
RGS [4]. A positive interaction is indicated by
+++ and no interaction by –––. LT, Leu–Trp–;
LTH, Leu–Trp–His–.
+++
+++
+++
+++
+++
+++
+++
+++
+++
+++
+++
+++
+++
+++
+++
+++
-–––
-–––
–––
–––
–––
+++
+++
+++
–––
–––
–––
–––
–––
–––
–––
–––
APC #2 1516–1595
mAPC2 1275–1634
APC #1 1464–1604
mAPC2 1275–1585
mAPC2 1275–1371
mAPC2 1351–1585
mAPC2 1351–1634
SAMP SAMP
Current Biology   
20
amino
acids
20 
amino
acids
SAMP
20
amino
acids
 
VP16 AD PGBT9 PGBT9-RGS
   LT        LTHLT        
   
LTH
Figure 4
Control of β-catenin signalling by APC2 in
colorectal cancer cells. (a) The APC–/–
SW480 cells or (b) the HCT116 cells
containing mutant β-catenin were transfected
with the Tcf reporter plasmid pTOPTKFLASH
(TOP; 200 ng) or the mutant reporter
pFOPTKFLASH (FOP; 200 ng), in combination
with the indicated amounts of APC2 or APC
expression vectors, the corresponding amount
of empty ‘stuffer’ expression vector (pCDNA3),
and the internal transfection control Renilla
luciferase plasmid (pRL-TK; Promega),
essentially as described in [18]. For each
sample, values are given as the ratio of
luciferase activity to Renilla activity. Although
pTOPTKFLASH is actively transcribed in both
cell lines, inhibition of its transcription by APC2
is observed only in the APC–/– cells. 
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addition, the downregulation of endogenous β-catenin in
SW480 cells transiently transfected with APC2 was visual-
ized by immunofluorescence. Control cells showed speck-
led nuclear staining, whereas nuclear staining was absent in
cells transfected with APC2 (Figure 5).
Its similarities with APC would predict APC2 to be a
tumour-suppressor protein. It has always been puzzling why
the overwhelming majority of neoplasms in familial adeno-
matous polyposis patients occur in the intestine, while APC,
β-catenin and Tcf factors are much more broadly expressed.
It is possible that APC and APC2 perform a redundant
tumour-suppressor function in many tissues. The identifica-
tion of APC2 and dAPC2 will allow the creation of mouse
and fly strains that are mutant for these genes. Such animal
models will shed more light on the unique functions of
these genes and on their interactions with other compo-
nents of the Wnt pathway.
While this manuscript was being reviewed, the sequence
of the human APC2 gene was published by H. Nakagawa
et al. [23].
Supplementary material
Further details of dAPC and dAPC2 and the mouse APC2 gene, and the
expression levels of human APC and APC2 in a variety of tissues are
published with this article on the internet.
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Figure 5
Downregulation of endogenous β-catenin by APC2 in SW480 cells.
SW480 cells were (a) mock-transfected with an empty vector or
(b) transiently transfected with APC2. Endogenous β-catenin was
visualized 24 h later by immunofluorescence using antibodies from
Transduction laboratories.
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Figure S1
A novel Drosophila APC homologue.
(a) Comparison of dAPC with dAPC2.
Domains conserved between the APC
homologues are indicated by boxes. (b) The
homologies between the 15 amino acid and
20 amino acid repeats of dAPC and dAPC2
are shown. The dAPC2 accession number is
AF091430.
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Basic domain
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20 amino acid repeats 
dAPC rpt1 YCEEGTPGYFSRYDSLSSLD
dAPC2 rpt1 YCEEGTPGSFSRFDSLNSLT
dAPC rpt2 NSALETPLMFSRRSSMDSLV
dAPC2 rpt2 DSALETPLMFSRRSSMDSLV
dAPC rpt3 FNVEHTPAQFSTATSLSNLS
dAPC2 rpt3 FHVEHTPAAFSCATSLSNLS
dAPC rpt4 YCTEDTPALLSKVPSNTNLS
dAPC2 rpt4 YCTEDTTAVLSKAPSNSDLS
dAPC rpt5 FLVEDSPCNFSVVSGLSNLT
dAPC2 rpt5 YYVEDSPCTFSVISGLSHLT
15 amino acid repeats  
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dAPC rpt1 TEEQPIDYSVKYSEN
dAPC2 rpt1 TEEQPIDYSMKYMEH
dAPC rpt2 DLDQPTDFSLRYAEN
dAPC2 rpt2 DLDQPTDFSARYKER
dAPC rpt3 TEDTPYVISNAASVT
73% identity
  
Figure S2
Expression of human APC2. Dot blots of 50 normalized poly(A) mRNA
samples isolated from a large variety of tissues (and several controls)
were hybridized with probes corresponding to the 5′ end of the APC2
and APC genes, according to the manufacturer’s instructions (RNA
Master Blot 7770-1, Clonetech). Although all tissue RNA samples
yielded positive signals with both probes when compared to control
RNA samples supplied on the blot, high levels of expression for both
genes were observed throughout the central nervous system. Relative
differences between APC and APC2 expression in a selected set of
tissues are shown. The signals on individual dots were quantified by
phosphorimaging; the signals obtained for the bladder mRNA samples
were arbitrarily set at 1 for each of the individual probes and the
background obtained with human Cot1 DNA was set at 0.
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Whole brain
Spinal cord
Heart
Foetal kidney
Bone marrow
Lung
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Small intestine
APC APC2
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Table S1
Genomic organisation of mouse APC2.
Intron Exon Exon number Exon length Exon Intron
1 141 g aag GTGAGAGCCTGCATGGAG
AGACCATGCCCGCAG gag g 2 91 aaa g GTGAGTGACTTCCAGAAC
CCTCCCTCCCTCCAG ct ct 3 181 ag ag GTGAGAGGGCGTGGGAAA
CATCCCCTCCACCAG a tgc 4 109 c acg GTGAGCTCCCATCGTACC
GCCCCCTCCCAGCAG ttt t 5 114 g cag GTGCGGGCAGTGCACACC
TTCTCTGTTCTCTAG atc c 6 78 t cag GTACCAAGACAAGCAGGG
ATGTTCTTCCTGCAG gct c 7 99 c aag GTAAGAAGGGAAAATCTG
CGTGTTCCCCTGCAG gtg g 8 373 gaa a GTGGTACAGGAGACAGTG
CACGCCTGCCCACAG ct cc 9 96 cta g GTGGGGTGTCCCCATCT
TTCCCACACCTACAG gg gg 10 140 c aag GTTCCTAGGGTGGGAAGA
TGTCAATCCCAACAG gcc a 11 78 t cag GTACACAGGGCAGGGGAG
TCCCACCCTGGTCAG gtt g 12 117 c aag GTGAGCATGGGCAGCCTG
TCCCTCCCACCCCAG gag t 13 215 ac ag GTCAGCTCCCATCACGAT
TCTGGGTTTCCCCAG g cag 14 4990
Genomic organization of the mouse APC2 gene. A genomic fragment of mouse APC2 was obtained by PCR using primers based on human
sequence in the Armadillo repeat region. A mouse genomic P1 library was subsequently screened by Genome Systems using primers based on
the cloned mouse fragment. The P1 clone obtained was used to clone and sequence mouse APC2 using standard procedures.
